NLRP3 and COVID-19: Accordingly, we detected the increased expression level of NLRP3 in alveolar macrophages and syncytium from autopsies of COVID-19 patients with severe disease, and observed the activation of NLRP3 inflammasome during the infection of PMA-treated THP1 macrophages with SARS-CoV-2 in vitro.